Literaturliste 2006
Literaturliste 2006
Literaturliste 2006
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Meissner, A, Lammert F, von Unruh G<br />
Kalziumoxalat-Urolithiasis bei Patienten mit Morbus Crohn.<br />
Uro-News. 2005: 69-70.<br />
Mobius U, Lubach-Ruitman M, Castro-Frenzel B, Stoll M, Esser S, Voigt E,<br />
Christensen S, Rump JA, Fätkenheuer G, Behrens GM, Schmidt RE.<br />
Switching to atazanavir improves metabolic disorders in<br />
antiretroviral-experienced patients with severe hyperlipidemia.<br />
J Acquir Immune Defic Syndr. 2005 Jun 1;39(2):174-80.<br />
Mocroft A, Soriano V, Rockstroh J, Reiss P, Kirk O, de Wit S, Gatell J, Clotet B,<br />
Phillips AN, Lundgren JD; EuroSIDA Study Group.<br />
Is there evidence for an increase in the death rate from liver-related disease in patients<br />
with HIV?<br />
AIDS. 2005 Dec 2;19(18):2117-25.<br />
Mocroft A, Phillips AN, Soriano V, Rockstroh J, Blaxhult A, Katlama C, Boron-<br />
Kaczmarska A, Viksna L, Kirk O, Lundgren JD; EuroSIDA Study Group.<br />
Reasons for stopping antiretrovirals used in an initial highly active antiretroviral regimen:<br />
increased incidence of stopping due to toxicity or patient/physician choice in patients with<br />
hepatitis C coinfection.<br />
AIDS Res Hum Retroviruses. 2005 Sep;21(9):743-52.<br />
Mocroft A, Phillips AN, Soriano V, Rockstroh J, Blaxhult A, Katlama C, Boron-<br />
Kaczmarska A, Viksna L, Kirk O, Lundgren JD; The EuroSIDA Study Group.<br />
Reasons for stopping antiretrovirals used in an initial highly active antiretroviral regimen:<br />
increased incidence of stopping due to toxicity or patient/physician choice in patients with<br />
hepatitis C coinfection.<br />
AIDS Res Hum Retroviruses. 2005 Jun;21(6):527-36.<br />
Mocroft A, Rockstroh J, Soriano V, Ledergerber B, Kirk O, Vinogradova E, Reiss P,<br />
Katlama C, Phillips AN, Lundgren JD; EuroSIDA Study Group.<br />
Are specific antiretrovirals associated with an increased risk of<br />
discontinuation due to toxicities or patient/physician choice in patients with hepatitis C<br />
virus coinfection?<br />
Antivir Ther. 2005;10(7):779-90.<br />
Musch A, Rabe C, Paik MD, Berna MJ, Schmitz V, Hoffmann P, Nischalke HD,<br />
Sauerbruch T, Caselmann WH.<br />
Altered expression of TGF-beta receptors in hepatocellular carcinoma—effects of a<br />
constitutively active TGF-beta type I receptor mutant.<br />
Digestion. 2005;71(2):78-91<br />
Nagano M, Stubiger G, Marchetti M, Gmeiner G, Allmaier G, Reichel C.<br />
Detection of isoforms of recombinant human erythropoietin by various plant lectins after<br />
isoelectric focusing.<br />
Electrophoresis. 2005 May;26(9):1633-45.<br />
Nattermann J, Schneiders AM, Leifeld L, Langhans B, Schulz M, Inchauspe G, Matz<br />
B, Brackmann HH, Houghton M, Sauerbruch T, Spengler U.<br />
Serum antibodies against the hepatitis C virus E2 protein mediate antibody-dependent<br />
cellular cytotoxicity (ADCC).<br />
J Hepatol. 2005 Apr;42(4):499-504.